April 2020 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for April 2020. This roundup includes...
Across U.S., Wide Variation Seen in Thyroidectomy Rates
Rate per 100,000 Medicare beneficiaries ranges from 22 to 139, a 6.2-fold difference
Health Care Spending Up, Mainly Due to Rising Prices
Spending increasing despite no change or decline in utilization of most health care services
Short-Lived Benefits for Abusive Supervisory Behavior
Positive indirect effect on work engagement via recovery level, which is short-lived
Progress Toward Cutting Racial Mortality Disparities Stalling, Reversing
Progress reversed due to increase in mortality from external causes, stagnation for cardiovascular diseases
Most Female Physicians Have Faced Sexist Patient Comments
Sexual harassment by patients can negatively affect physician-patient relationship, quality of care
Diabetes Impacts Mortality in Breast Cancer Patients
Longer duration of DM, pre-existing CVD increased all-cause and cancer-specific mortality
Pay for Performance Cuts Mortality in Diabetes Patients
Program associated with lower risk for mortality, but not cancer incidence
CDC: Counterfeit Drugs From Online Pharmacies Pose Considerable Danger
Agency notes that counterfeit pills often contain fentanyl and methamphetamine
Online Ratings Not Aligned With Objective Quality Measures
In addition, consumer ratings are consistent across platforms for specialist physicians
